6533b86cfe1ef96bd12c80c0

RESEARCH PRODUCT

sj-docx-1-tam-10.1177_17588359231151845 – Supplemental material for Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay

Lorena IncorvaiaGaetana RinaldiGiuseppe BadalamentiAlessandra CucinellaChiara BrandoGiorgio MadoniaAlessia FiorinoAngela PipitoneAlessandro PerezFederica Li PomiAntonio GalvanoValerio GristinaNadia BarracoMarco BonoTancredi Didier Bazan RussoFrancesca ToiaAdriana CordovaDaniele FanaleAntonio RussoViviana Bazan

subject

110203 Respiratory DiseasesFOS: Clinical medicine111702 Aged Health CareFOS: Health sciences111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified111299 Oncology and Carcinogenesis not elsewhere classified

description

Supplemental material, sj-docx-1-tam-10.1177_17588359231151845 for Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay by Lorena Incorvaia, Gaetana Rinaldi, Giuseppe Badalamenti, Alessandra Cucinella, Chiara Brando, Giorgio Madonia, Alessia Fiorino, Angela Pipitone, Alessandro Perez, Federica Li Pomi, Antonio Galvano, Valerio Gristina, Nadia Barraco, Marco Bono, Tancredi Didier Bazan Russo, Francesca Toia, Adriana Cordova, Daniele Fanale, Antonio Russo and Viviana Bazan in Therapeutic Advances in Medical Oncology

https://dx.doi.org/10.25384/sage.22110160.v1